Stay updated on Ravulizumab Study in LN/IgAN Clinical Trial

Sign up to get notified when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ravulizumab Study in LN/IgAN Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.4%
    Check dated 2025-04-30T13:42:17.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial on lupus nephritis and IgAN, while adding new information about participant masking and a new version revision.
    Difference
    15%
    Check dated 2025-04-16T01:23:25.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 23, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.4%
    Check dated 2025-04-08T19:52:26.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version, v2.14.3, with a new last update date of March 25, 2025, replacing the previous version v2.14.2 and its last update date of January 23, 2025.
    Difference
    0.5%
    Check dated 2025-04-01T13:43:52.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-25T04:50:23.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-18T02:25:04.000Z thumbnail image

Stay in the know with updates to Ravulizumab Study in LN/IgAN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.